medicare glp-1 coverage obesity Big News for Part D Patients! 🎉 Starting July 1, patients with Medicare Part D may qualify for medications (injection or oral) for as little as $50 per month. GLP-1 The weight of Medicare GLP-1

A study in The New England Journal of Medicine found that just 33% of the dose drove 72% of the weight loss at week 72 with a lower side effect profile

Comprehensive nutritional assessment Our registered dietitians get a complete picture of your nutritional needs by gathering details about your eating habits, lifestyle, and health goals

This often coincides with the body initial adaptive response to rapid weight loss

Your clients (and their tailbones) will thank you.

Barry D, Pietrzak RH, Petry NM

For example, patients with a BMI just below 27 but with significant metabolic dysfunction may still benefit from GLP-1 treatment, though prescribing in these cases is considered off-label and requires additional clinical justification